Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome

Table 2 The comparison of the dietary intake of the participants in placebo and OEA group before and after the intervention

Variable		Mean ± SD Placebo (n = 43)	Mean ± SD Oleoylethanolamide (n = 44)	P1
Energy(kcal)	Baseline	2179.36 ± 303.22	2257.11 ± 298.43	0.619
	End	2101.03 ± 319.09	2209.19 ± 308.11	0.683
	P2	0.656	0.693
Protein(gr)	Baseline	88.5 ± 21.19	91.34 ± 23.5	0.203
	End	88.03 ± 21.5	91.11 ± 24.5	0.21
	P2	0.35	0.394
Carbohydrate (gr)	Baseline	303 ± 49.5	308.12 ± 55.5	0.325
	End	302.29 ± 47.18	305.77 ± 53.09	0.38
	P2	0.45	0.401
Fat (gr)	Baseline	69.02 ± 4.5	68.11 ± 5.13	0.367
	End	66.09 ± 6.8	69.39 ± 6.07	0.291
	P2	0.265	0.31
Saturated fatty acids(gr)	Baseline	27.5 ± 4.21	26.15 ± 5.7	0.23
	End	25.03 ± 4.06	26.11 ± 5.1	0.207
	P2	0.19	0.311
Monounsaturated Fatty acid (gr)	Baseline	20.08 ± 3.19	22.13 ± 3.19	0.807
	End	20.1 ± 4.19	22.17 ± 3.55	0.59
	P2	0.298	0.74
Polyunsaturated Fatty acid (gr)	Baseline	19.63 ± 4.35	20.03 ± 4.41	0.213
	End	19.18 ± 3.13	20.16 ± 4.6	0.204
	P2	0.269	0.293
Fiber(gr)	Baseline	9.16 ± 2.9	10.04 ± 3.33	0.136
	End	9.87 ± 2.12	10.22 ± 3.08	0.14
	P2	0.157	0.148
Vitamin C (mg)	Baseline	69.21 ± 17.5	70.77 ± 14.32	0.415
	End	68.65 ± 19.2	70.54 ± 12.77	0.302
	P2	0.288	0.311
Vitamin E (IU)	Baseline	11.31 ± 2.02	11.59 ± 3	0.289
	End	11.06 ± 2.31	11.24 ± 2.66	0.231
	P2	0.24	0.267
Selenium (mcg)	Baseline	116.14 ± 29.5	117.02 ± 35.7	0.354
	End	116.02 ± 25	117.6 ± 34.61	0.329
	P2	0.39	0.402

Data are expressed as means ± SD
P1: Comparison of the mean of variables between the two groups of OEA and placebo (Independent samples t-test)
P2: Comparison of mean of variables in each group at baseline and end of study (Paired samples t-test)

ISSN: 1757-2215